Photo by scottwebb from unsplash
We thank Drs Yu and Liu for their interest in our article.1 With respect to their query about the use of systemic anticoagulation, we have several points. In the International… Click to show full abstract
We thank Drs Yu and Liu for their interest in our article.1 With respect to their query about the use of systemic anticoagulation, we have several points. In the International Stroke Trial in adults, patients given heparin were shown to have significantly fewer recurrent ischemic strokes within 2 weeks. However, this benefit was completely offset by a similar-sized increase in hemorrhagic stroke, and thus, heparin is not recommended for the treatment of ischemic stroke in adults.2 However, the risk factors for hemorrhagic conversion, including advanced …
Journal Title: Stroke
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!